Minimally invasive heart surgery

Displaying 5 studies

  • Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) No Locations

    This study will evaluate the efficacy of ranolazine as compared with placebo when used as part of standard medical therapy in chronic angina subjects with incomplete revascularization post-PCI on the composite of ischemia-driven revascularization or ischemia-driven hospitalization without revascularization.

  • A Study of Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure Rochester, MN

    The purpose of this study is to demonstrate acute effectiveness and safety of minimally-invasive pericardiotomy in patients with Heart Failure (HFpEF).

  • A Study Using Lactated Ringer's Solution versus 5%Human Albumin in Cardiac Surgery Patients Rochester, MN

    The purpose of this study is to compare the total fluid volume of using 5% human albumin and Lactated Ringer's in the perioperative cardiac surgical patient. Our hypothesis is that the individual total fluid volume will be less with 5% human albumin compared to Lactated Ringer's in the perioperative cardiac surgical patient.

  • A Study to Evaluate the Effectiveness and Safety of D-PLEX in the Prevention of Sternal Infection Post- Cardiac Surgery Rochester, MN

    The purpose of this study is to assess the effectiveness and safety of D-PLEX administered concomitantly over a period of 90 days (3 months)with the standard of care (SOC) IV prophylactic antibiotic treatment vs. SOC in prevention of post-cardiac surgery sternal infections.

  • New-onset Atrial Fibrillation and Flutter Following Cardiac Surgery Rochester, MN

    The aims of this investigation are:

    To assess the predictive value (and accuracy) of clinical and physiologic preoperative variables in identifying patients at risk for the development of new-onset atrial arrhythmia after cardiac surgery.

    To assess the feasibility of a physiological risk model based on clinical and echocardiographic indexes to predict post-operative AF.

    To assess the role of prophylactic agents in the prevention of new-onset postoperative POAF

    To assess the economic impact of new-onset postoperative AF:

    • Length of hospital stay (will be measured as fractions of days)

    • Hospital cost (will be measured in standardized dollars)

    • Resource utilization (will be measured by resource-based relative-value units)

    To assess the outcome ...

.

Mayo Clinic Footer